This company recently went public with an IPO on Friday, September 18th 2026. They issued 23,333,334 shares at $14.00 - $16.00 per share. We will continue to update data for ETRA as it becomes available. NASDAQ:ETRA Electra Therapeutics (ETRA) Stock Price, News & Analysis $11.55 -0.27 (-2.28%) As of 09/25/2026 04:00 PM Eastern Add Share Share Stock Analysis Stock AnalysisChartInsider TradesSEC Filings About Electra Therapeutics Stock (NASDAQ:ETRA) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get Electra Therapeutics alerts:Sign Up Key Stats Today's Range$11.27▼$12.7550-Day Range N/A52-Week Range$11.27▼$15.50Volume438,379 shsAverage Volume1.54 million shsMarket Capitalization$724.99 millionP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company Overview Electra Therapeutics, Inc. is a clinical-stage biopharmaceutical company developing therapies for severe immune-mediated diseases. The company is focused on creating treatments designed to selectively remove disease-causing immune cells while preserving healthy immune cells. Electra’s lead product candidate, ELA026, is an investigational antibody being developed for conditions involving harmful immune-cell activity. The company is evaluating the candidate in clinical studies for diseases including systemic sclerosis and immune thrombocytopenia. Electra Therapeutics is headquartered in the United States and is focused primarily on advancing its pipeline through clinical development. Information about additional commercial products, international operations and company leadership is limited.AI Generated. May Contain Errors. Read More Receive ETRA Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Electra Therapeutics and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. ETRA Stock News HeadlinesElectra Therapeutics (NASDAQ:ETRA) Stock Bumped Up to Hold by Wall Street ZenSeptember 26 at 1:36 AM | americanbankingnews.comElectra Therapeutics (NASDAQ:ETRA) Stock: Insider Orbimed Advisors Llc Acquires 1,333,333 SharesSeptember 25 at 4:09 AM | americanbankingnews.comALERT: Drop these 5 stocks before the market opens tomorrow!The Wall Street Journal is already raising the alarm about a potential market crash, and Weiss Ratings research points to the first half of 2026 as a particularly rough stretch for certain holdings. Some of America's most popular stocks could take serious damage as a radical market shift plays out. Analysts at Weiss Ratings have identified five names you may want to remove from your portfolio before this unfolds. If any of these are in your portfolio, now is the time to review your positions. | Weiss Ratings (Ad)Electra Therapeutics (NASDAQ:ETRA) Stock: Insider Carl Gordon Buys 1,333,333 SharesSeptember 25 at 4:09 AM | americanbankingnews.comElectra Therapeutics IncSeptember 24 at 1:16 PM | money.usnews.comInsider Buying: Electra Therapeutics (NASDAQ:ETRA) Director Buys $19,999,995.00 in StockSeptember 24 at 5:37 AM | insidertrades.comElectra Therapeutics, Inc.(NasdaqGS:ETRA) added to NASDAQ Composite IndexSeptember 22, 2026 | marketscreener.comMHBM Healthcare Investments Announces IPO of Portfolio Company Electra TherapeuticsSeptember 21, 2026 | markets.ft.comSee More Headlines ETRA Stock Analysis - Frequently Asked Questions How have ETRA shares performed this year? Electra Therapeutics' stock was trading at $13.25 on September 18, 2026. Since then, ETRA stock has decreased by 12.8% and is now trading at $11.55. When did Electra Therapeutics IPO? Electra Therapeutics (ETRA) raised $350 million in an IPO on Friday, September 18th 2026. The company issued 23,333,334 shares at a price of $14.00-$16.00 per share. When does Electra Therapeutics' quiet period expire? Electra Therapeutics's quiet period expires on Wednesday, October 28th. Electra Therapeutics had issued 23,333,334 shares in its initial public offering on September 18th. The total size of the offering was $350,000,010 based on an initial share price of $15.00. During Electra Therapeutics' quiet period, underwriters and any insiders that worked on the IPO are prevented from issuing any research reports for the company because of regulations issued by the Securities and Exchange Commission. Following the end of the company's quiet period, it's expected that the brokerages that served as underwriters on the stock will initiate research coverage on the company. How do I buy shares of Electra Therapeutics? Shares of ETRA stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Company Calendar Today9/27/2026Fiscal Year End12/31/2026Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorN/A Industry N/A Sub-IndustryN/A Current SymbolNASDAQ:ETRA CIK2088082 Webwww.electra-therapeutics.com Phone888-743-2290FaxN/AEmployees46Year FoundedN/AProfitability EPS (Trailing Twelve Months)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding Shares62,770,000Free FloatN/AMarket Cap$724.99 million OptionableN/A BetaN/A The 7 Hottest IPO Stories of 2026MarketBeat just released its list of the 7 hottest IPOs expected to hit Wall Street in 2026. See which companies are preparing to go public and why investors are watching closely.Get This Free Report This page (NASDAQ:ETRA) was last updated on 9/27/2026 by MarketBeat.com Staff. From Our PartnersALERT: Drop these 5 stocks before the market opens tomorrow!The Wall Street Journal is already raising the alarm about a potential market crash, and Weiss Ratings researc...Weiss Ratings | SponsoredSmall Colorado Company (Backed by Sam Altman) Could Save U.S. Power GridA small Colorado company has secured rights to technology that could prevent the U.S. public power grid from c...Altimetry | SponsoredLouis Navellier: My #1 AI stock for 2026 (name & ticker inside)Louis Navellier's Stock Grader system helped him flag Nvidia before its 82,000% run and has identified the top...InvestorPlace | SponsoredReady to give options a try? Your first trade (Ticker included) -INSIDETired of trying tactic after tactic when it comes to options trades... only to be met with market noise and st...Base Camp Trading | SponsoredHere’s the stock symbol I’ve promisedWhitney Tilson of Stansberry Research has long recommended Berkshire Hathaway as a core retirement holding - b...Stansberry Research | SponsoredHere’s Why Trump Won’t End The Iran WarTrump has called an Iran deal close 38 times since the war began, yet the fighting keeps flaring back up. O...Banyan Hill Publishing | SponsoredBank of America: 'Digital Dollar Inevitable'Bank of America just revealed your expiration date. In their Bloomberg interview, they didn't just predict the...Decentralized Masters | SponsoredThese gold assets are priced for $1,800 gold [it's over $4,000]Gold's major miners are generating record free cash flow, with margins as high as 75 percent even after gold's...Golden Portfolio | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Electra Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Electra Therapeutics With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free ETRA Stock Alerts